Neoadjuvant relatlimab clinical trials

Neoadjuvant Study With Combination Immuno-oncology for Primary Clear Cell Renal Cell Cancer

This study is looking at different combinations of immunotherapy medicines given before surgery for kidney cancer. It aims to see if these treatments can shrink tumours and improve outcomes for people with clear cell renal cell carcinoma.